Subscribe To
Why shares of bioxcel therapeutics fell this week
The company has one marketed treatment -- Igalmi, which reduces agitation in patients with bipolar disorder or schizophrenia. The most advanced candid...
September 28, 2023, 5:35 pm
Wegovy drugmaker novo nordisk to make $70bn a year from weight-loss alone, as analysts await full select trial data
As researchers work to test whether Novo Nordisk (NYSE:NVO)'s fat-busting drug Wegovy can also be used as a treatment for ...
September 7, 2023, 11:09 am
Quest diagnostics launches alzheimer's blood test for consumers
Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein whic...
July 31, 2023, 7:10 am
: depression diagnosed in early or mid-adulthood linked to dementia: study
The risk of dementia was higher for men than women. Read Full Story The post : Depression diagnosed in ...
July 29, 2023, 7:51 pm
Biovie's clinical dementia drug ne3107 shown to reduce dna methylation
BioVie Inc (NASDAQ:BIVI) presented a poster over the weekend showcasing the epigenetic basis for how its drug candidate NE3107 may have regulated spec...
July 17, 2023, 9:09 am
Leqembi approval offers renewed hope for novel alzheimer's disease treatments
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated w...
July 10, 2023, 4:43 pm
Quest diagnostics (dgx) presents new data on disease testing
Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for d...
July 3, 2023, 12:12 pm
Google deepmind ceo calls for ramped up government funding to mitigate ai risks
Google DeepMind CEO and Co-Founder Demis Hassabis says governments should prioritize increased investment in AI safety research to mitigate risks. Spe...
June 12, 2023, 1:07 pm
Cassava (sava) up on progress with alzheimers disease study
Cassava (SAVA) made positive progress with simufilam, an oral drug treatment for Alzheimer's disease dementia. The company's shares gain in the last m...
May 30, 2023, 1:11 pm
Passage bio reports first quarter 2023 financial results and provides recent business highlights
On track to report interim clinical data for two lead programs, PBGM01 for GM1 gangliosidosis and PBFT02 for frontotemporal ...
May 11, 2023, 11:00 am
Urinary catheters market value to expand at a 4.5% cagr from 2021 to 2028, reaching usd 5.1 billion: tmr report
A urinary catheter is a semi-flexible tube used to empty the bladder of urine. Urinart catheter usage is advised by doctors in the event of urine inco...
May 5, 2023, 6:30 pm
Brett arends’s roi: two breakthroughs on dementia (maybe)
Read Full Story The post Brett Arends’s ROI: Two breakthroughs on dementia (maybe) appeared first on ...
April 23, 2023, 11:01 am
Biovie's degenerative dementia drug candidate to be presented at psychiatry conference
BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its Phase 2 open-label trial of its degenerative ...
April 20, 2023, 10:24 am
: can a person with dementia get divorced? the legal and financial concerns.
As the population ages, dementia complicates gray divorce proceedings. Read Full Story The post : Can a...
April 17, 2023, 4:41 pm
Biovie to present phase 2 trial data abstracts at 2023 american academy of neurology annual meeting
BioVie announced that data abstracts from its Phase 2 trials evaluating NE3107 in degenerative dementias and Parkinson's disease will be presented at ...
April 17, 2023, 12:01 pm
The margin: what is ftd? bruce willis has frontotemporal dementia, the most common form of dementia in people under 60
Here are the risk factors, symptoms and resources you need to know about frontotemporal dementia Read F...
February 16, 2023, 11:14 pm
Cardiovascular disease linked to worse brain health in middle age: research
Cardiovascular diseases such as heart disease and stroke have been associated with an increased risk for cognitive impairment and ...
January 28, 2023, 11:14 pm
Biovie inc: a catalyst-rich year ahead
BioVie's pipeline indications represent a combined addressable market size of more than $100 billion with high unmet medical needs. Phase 2 trials hav...
January 16, 2023, 12:04 am
New alzheimer's drug slows decline in memory - fuelling hope doctors will one day cure dementia
Doctors have hailed a "new era" of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer's....
November 29, 2022, 8:09 pm
Eli lilly stock starts on front foot after rival alzheimer trial fails
Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clini...
November 14, 2022, 10:09 am